Licensed Product Development. 4.2.1 Prior to the NDA Response Date, the Council in reasonable consultation with LICENSEE will use Commercially Reasonable Efforts to undertake the development and regulatory approval efforts toward obtaining a first approval of the NDA for the Licensed Product in the United States, at Council’s cost and expense.
Appears in 3 contracts
Sources: License Agreement, License Agreement, License Agreement (TherapeuticsMD, Inc.)